doi:10.3969/j.issn.1673-8640.2016.03.012

Abstract

CLC Number:

R446.11

Figures/Tables 5

References 10

1	李曦,李艳芳.不同年龄冠心病患者血尿酸水平变化特点的临床分析[J].中华老年心脑血管病杂志,2010,12(7):614-616.
2	谢学勤,张秀英,赵冬,等.北京市居民冠心病住院率及其变化趋势[J].中华心血管病杂志,2012,40(3): 188-193.
3	VOSBERGEN S,JANZEN J, STAPPERS PJ,et al.A qualitative participatory study to identify experiences of coronary heart disease patients to support the development of online self-management services[J].Int J Med Inform,2013,82(12):1183-1194.
4	孟秀君,胥丽霞,侯华,等.辽宁省城市居民冠心病患病现状及影响因素调查分析[J].中国医科大学学报,2011,40(10):915-918.
5	冷文修,何昆仑,范利,等.BNP和NT-proBNP在鉴别舒张性心力衰竭中的应用研究[J].中华检验医学杂志,2010,33(4):328-332.
6	殷建瑞,张波,谭丽华,等.丁苯酞对缺氧缺糖条件下血管内皮细胞VEGF和HIF-1α表达的影响[J].中国病理生理杂志,2011,27(4):643-647.
7	KANG WK,LEE MH,KIM YH,et al.Enhanced secretion of biologically active,non-glycosylated VEGF from Saccharomyces cerevisiae[J]. J Biotechnol,2013,164(4):441-448.
8	廖予婕. cTnI、hs-CRP和BNP在心力衰竭患者治疗前后的变化及其对诊断和预后判断的价值[J].检验医学,2010,25(2):92-95.
9	贺岩,李富荣,杜宗孝,等.血清BNP、hs-CRP、cTnI及UA联合检测对心力衰竭的临床价值[J].检验医学,2012,27(8):647-650.
10	毛小红. 冠心病患者血清VEGF和hs-CRP水平的变化[J].检验医学,2013,28(11):1050-1051.

组别	例数	性别（男/女）	年龄（岁）	体重指数（kg/m²）	高血压[例数（%）]	糖尿病[例数（%）]
CHD组	108	58/50	69.42±11.36	24.08±5.13	81（75.00）	37（34.26）
对照组	50	31/19	67.48±9.52	24.63±3.54	43（39.81）	14（28.00）
统计值		0.956^*	1.039^#	0.681^#	2.449^*	0.613^*
P值		>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	性别（男/女）	年龄（岁）	体重指数（kg/m²）	高血压[例数（%）]	糖尿病[例数（%）]
CHD组	108	58/50	69.42±11.36	24.08±5.13	81（75.00）	37（34.26）
对照组	50	31/19	67.48±9.52	24.63±3.54	43（39.81）	14（28.00）
统计值		0.956^*	1.039^#	0.681^#	2.449^*	0.613^*
P值		>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	BNP（ng/mL）	VEGF（ng/mL）	hs-CRP（mg/L）
CHD组	108	298.52±90.61	337.74±102.31	16.78±5.19
对照组	50	35.67±10.83	127.67±38.44	3.06±0.95
t值		20.411	14.047	18.519
P值		<0.05	<0.05	<0.05

组别	例数	BNP（ng/mL）	VEGF（ng/mL）	hs-CRP（mg/L）
CHD组	108	298.52±90.61	337.74±102.31	16.78±5.19
对照组	50	35.67±10.83	127.67±38.44	3.06±0.95
t值		20.411	14.047	18.519
P值		<0.05	<0.05	<0.05

组别	例数	BNP（ng/mL）	VEGF（ng/mL）	hs-CRP（mg/L）
AMI组	21	486.75±153.63	548.92±167.55	24.29±7.32
UAP组	56	334.08±104.90^*	364.21±115.17^*	17.21±5.63^*
SAP组	31	69.42±21.34^*#	194.63±51.28^*#	5.86±1.20^*#
F值		17.592	16.301	12.536
P值		<0.05	<0.05	<0.05

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 10

Related Articles 15

Recommended Articles

Metrics

组别	例数	BNP（ng/mL）	VEGF（ng/mL）	hs-CRP（mg/L）
单支病变组	39	131.67±48.81	177.49±68.73	10.57±3.12
双支病变组	42	295.41±93.53^*	305.64±98.40^*	17.04±5.83^*
三支病变组	31	371.56±128.47^*#	426.53±132.06^*#	20.74±6.10^*#
F值		14.683	16.409	6.700
P值		<0.05	<0.05	<0.05

组别	例数	BNP（ng/mL）	VEGF（ng/mL）	hs-CRP（mg/L）
轻度狭窄组	45	130.68±38.95	168.52±49.06	9.04±2.95
中度狭窄组	23	347.48±114.43^*	358.69±109.58^*	14.32±4.51^*
重度狭窄组	40	415.73±120.08^*#	503.67±164.73^*#	22.46±6.40^*#
F值		15.693	17.830	12.421
P值		<0.05	<0.05	<0.05

[1]	LI Li, SHI Huaying, Zaxiyangzong , Dawazhuoma , CHEN Yanmei, YANG Chunjiao, WEN Honglin. Application of indirect method in establishing reference range of adult blood lipids in Lhasa [J]. Laboratory Medicine, 2025, 40(11): 1064-1069.
[2]	SHEN Zhiying, CHEN Ming, DONG Yueying. Correlation between serum Hcy，S100B levels and cerebral metabolite indicators and cognitive impairment in elderly AIS patients [J]. Laboratory Medicine, 2025, 40(11): 1097-1101.
[3]	CHEN Wenli, JIN Cheng, ZHOU Lulu, XU Weiyi. Role of MicroR in guiding platelet count re-examination [J]. Laboratory Medicine, 2025, 40(9): 897-900.
[4]	WANG Qiuju, XIAO Huijian, WU Shuang, ZHAO Wanting, DAI Xubo, ZHUANG Yuepeng. Role of peripheral blood lymphocyte morphological classification in curative effect judgment of critical influenza [J]. Laboratory Medicine, 2025, 40(9): 901-906.
[5]	ZHANG Hui, YUAN Jingwen, ZHANG Chi. Adult reference ranges for platelet count and platelet-related parameters using fluorescence method in Wuhan [J]. Laboratory Medicine, 2025, 40(9): 892-896.
[6]	SHI Shaoxin, CHEN Xueting, XU Xiaofeng, LU Renquan, GUO Lin, ZHUANG Yihui. Role of coagulation function in bacterial bloodstream infection among malignant tumor patients [J]. Laboratory Medicine, 2025, 40(8): 804-809.
[7]	JIANG Fengying, JIANG Yun, MI Rui, QIAN Ximing, WANG Qiubo. Changes of platelet and coagulation function indicators in elderly patients with diabetic foot ulcers [J]. Laboratory Medicine, 2025, 40(7): 708-712.
[8]	YAO Lifeng, ZHANG Ling. Research progress on clinical significance of monocyte distribution width in infection and inflammatory diseases [J]. Laboratory Medicine, 2025, 40(5): 503-507.
[9]	DAI Jingwen, YANG Shuo, WANG Chong, SUN Lin, GU Meixiu, XIAN Jingrong, PAN Baishen, WANG Beili, ZHANG Chunyan, GUO Wei. Role of preoperative mean corpuscular hemoglobin concentration for predicting postoperative recurrence in intrahepatic cholangiocarcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 344-349.
[10]	ZHANG Haoyang, LU Lin, ZONG Ming, HE Long, DING Yuanyuan, FAN Lieying. Diagnostic and predictive value of white blood cell population data in patients with sepsis [J]. Laboratory Medicine, 2025, 40(3): 271-277.
[11]	ZHOU Jiakuan, GUO Ping, CAI Qi, YANG Mingkang, HUANG Zhixi, XUE Yilun, HUA Renxiang, LIN Han, LI Jiaming, WANG Jianbiao. Molecular epidemiological analysis of patients with increased stomatocytes and giant platelets in peripheral blood [J]. Laboratory Medicine, 2025, 40(2): 171-177.
[12]	WANG Chengyun, GU Ping, PAN Qiuhui, WANG Jing. Changes and clinical value of blood coagulation indexes in children with infection [J]. Laboratory Medicine, 2025, 40(2): 178-181.
[13]	. [J]. Laboratory Medicine, 2025, 40(2): 197-200.
[14]	ZHANG Lan, ZHU Jianfeng, PAN Baishen, CHEN Pu, WANG Beili, GUO Wei. Prognostic value of circulating plasma cells determined by morphology in newly diagnosed multiple myeloma [J]. Laboratory Medicine, 2025, 40(1): 15-19.
[15]	CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026.